 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.003.765 |
| Chemical and physical data | |
| Formula | C13H13N3O5S2 |
| Molar mass | 355.38 g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
Succinylsulfathiazole (also known as sulfasuxidine) is a sulfonamide.[1][2] It is also spelled as succinylsulphathiazole. It is a white or yellow-white crystalline powder. It dissolves in aqueous solutions of alkali hydroxides and carbonates but is very slightly soluble in water.
It is classified as ultra long-acting drug. About 95% of the drug remains in the intestine and only 5% is hydrolyzed, slowly, to sulfathiazole and is absorbed.
The drug is used for its antibacterial activity in the GIT. The dose is 10g - 20g daily in divided doses.
The Succinyl group is attached to form a prodrug for the controlled release of the drug sulfathiazole.
References[edit]
- ^ Poth EJ, Knotts FL (February 1942). "Clinical use of Succinylsulfathiazole". Archives of Surgery. 44 (2): 208. doi:10.1001/archsurg.1942.01210200024002. ISSN 0004-0010.
- ^ Dixon CF, Benson RE (October 1944). "Closure of Colonic Stoma: Improved Results With Combined Succinylsulfathiazole and Sulfathiazole Therapy". Annals of Surgery. 120 (4): 562–571. doi:10.1097/00000658-194410000-00012. PMC 1618178. PMID 17858511.